Feng Chi Biotech Corp. (TPEX:6744)
Taiwan · Delayed Price · Currency is TWD 15.50
0.00 (0.00%)
Sep 11, 2026, 12:50 PM CST
Feng Chi Biotech Market Cap
Feng Chi Biotech has a market cap or net worth of 238.7 million as of September 11, 2026. Its market cap has decreased by -23.27% in one year.
Market Cap
238.70M
Enterprise Value
71.39M
Revenue
156.99M
Ranking
n/a
PE Ratio
24.10
Stock Price
15.50
ChartMarket Cap Chart
Since September 25, 2019, Feng Chi Biotech's market cap has decreased from 742.28M to 238.70M, a decrease of -67.84%. That is a compound annual growth rate of -15.03%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 238.70M | -12.92% |
| Dec 31, 2025 | 274.12M | -10.10% |
| Dec 30, 2024 | 304.92M | -10.81% |
| Dec 29, 2023 | 341.88M | 11.00% |
| Dec 29, 2022 | 308.00M | -19.19% |
| Dec 28, 2021 | 381.15M | -16.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 25, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| TaiRx | 743.74M |
| BioLASCO Taiwan | 729.94M |
| MegaPro Biomedical | 711.93M |
| SynCore Biotechnology Co.,Ltd | 641.76M |
| Lukas Biomedical | 601.60M |
| LAUNXP Biomedical | 563.09M |
| TaiwanJ Pharmaceuticals | 551.24M |
| Taiwan Advance Bio-Pharmaceutical | 393.80M |